{"ticker": {"uuid": "c8155347-6882-4906-9d76-e7eabcbaab9e", "symbol": "DXB", "name": "Dimerix Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Dimerix acquires phase 2-ready kidney injury treatment DMX-652 By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNTjlmMzdKUzgyS09qLU05MnNkbEpnNVV6V3F2QnVfZUpBa2hyd0YxS29uNWZqT01tWk1UT3VIbzAtdDY1czR1TlVnZDYzRnBXTDBTMFlhT2VhWUtFZkhNdHhfNGxiYk5Leml4MncwTWUtbzJJMU14cndReGJwdks3RVhXOUpoU3J5dFZHXzYyMFR0aG0xTlNMeWZSX1NmY1NCbkNIMGl3NWUxUTNFLW96TG1TNjNpVnNFZUgzSU1ia2JIam5RMWU0YWFXVVl5dw?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-07-17T14:51:40+00:00", "published_display": "17 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPN09tTG11WmdwZFBKUENCa0FzeGVLN2dNdzJUMVJ3alhDYklGajh6ZDBwOEdYeGVkZnVEWUF0dkdicnBiT2xMMnVYZ1pOQ0YybVVnWW90QS1QOElGSWNaS3Q0Tm16dC1iYzZUVG1ObkNDbEhBbnVKZGVZa0UxU3pHZjdBcUduNmpHOUhJLUZuYWozTkpmYUlWX1FaNmQzeGl3NXVfTERWWDdrZ2pkRzdzVXFadFZfU29Eb1plWF94cFYtdThZWUhLaGlnN3Y1ZVBFLUhmajFRdE16RU5nS1NrRllOVQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-17T06:58:00+00:00", "published_display": "17 Jul 2026 06:58", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix Limited (ASX:DXB) Shares Rise 4.17% Intraday as the DMX-200 Kidney Story Gathers Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQWEpfcTRETlAxbzZUQW8xYnZOaXdLNzBkZ3VHbWdSUE5ZZ19FZE5vdlBQOEZjRmdCbnpDRTR4TUhhd2NhZ25mWGhKY0xSNlprOUpfczJ3MnhHZlN0cTlDUmFjSmRVTkFReTBnOEtic2w1MGdoSjBWYmtXNEozSmFpWEQ0NXh3Ql9zZWhoUWx5Q21weDJpSTlBbDRHQjhXUEpvdGt0YVlkeldGbDhmN3hEa3Rsc1BsNUdadk9nQzFNTDU5MW9BOTl3eHNZQkROQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T04:21:00+00:00", "published_display": "17 Jul 2026 04:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Is Fueling Today's Rally in Dimerix (ASX:DXB) Share Price?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMl9pZHRQSi1nWFBDZkNGRnFWOEMtZEtPTDJOUmtka3FMbk42VTJtcWVxQlZKa2JBcFJzNnB2TVJQTjYxc1M2ejR4U245ci1MNlVZdzJtNENzWTVPZWFzcmM5dGhNX3FuZ18wcnZHZFhRdjIwdUN1Q2xtOGZFV0dTV0NFMlFQNUtwM3pOX2l0VkpNUTlrY3Y0QVppM3BpUQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T02:44:00+00:00", "published_display": "17 Jul 2026 02:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix Acquires Therapeutic Asset From UK-Based Firm; Shares Up 8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWV9LUXJmMWhoTFdyeUtxTS1VaDJfREl6TThmMmdVSUo2a3lQb0piVzR1RF8yQ3N2V1p3cmVQYzNlYmdubkpXckd1NGNqVWd6LVYxVzFua0plenQtN254UTB4VVhqUWU3aHFxVlRkcXI3bVMzZ0Q3V3BBRFRvOEY1NngtVE9PZVoyQUFVd2lQd3BfSW9IZWFNYTJZc2RHcTBzbGd0MG5rUW82R0oxeHZZS29FRktHSTFvNXB3emtybWhIUF9Db2E5VzRhZWxnMTV3RkRPcm1YYw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-17T02:16:08+00:00", "published_display": "17 Jul 2026 02:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) buys DMX-652 and quietly rebuilds its story", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFB1SUxsUXg5VS1Gd29UbEZmVXRyV3JySVJhNWJFOWNjNDFBTUU0X2FjTUp3NzM3MHF2bGg2QjZRaDJRa1pUb2RlSDBtMk5hLWE2dHpMdlJIRTM2V2tVWGVJWk1XbE04ak9jZU5qRi1DZw?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-07-17T01:15:46+00:00", "published_display": "17 Jul 2026 01:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Shares Slip: Is the Market Underestimating the Biotechnology Company's Clinical Pipeline?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQOEJsck1DeWMxRTBpcGlWTzU0eVVqTXg4N0JwVmlFUVJuRmZDNlNsa0pkWTlaRjluQ0NBclhXWGZKQlZndW5PQzVwN1F5SVFOdHVJUmZxZHRBRk16dkRtbTZRbzkxRUp1dWFEVHpON296NEVZdnNfZmlhZ3d0QVF3aTRsT0Jpa2F1MDRTdmhoOThReEtpREVNY3ZwNjJpZng1WHJGWEU5RlM4dUJKQTY0U24zbHJVeXVuT2JzR091ZmR2ZjZreEUwZ05uWXppZDRucTdKU1pJUQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:13:00+00:00", "published_display": "13 Jul 2026 07:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could Dimerix (ASX:DXB) Be Approaching a Defining Regulatory Phase?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbE5lN0xFMTJ6bkwxSWlBQmU0V2swQjRfWGFPYzdITXRicUxxalZ1YW96TGtZNGtPWndQeThxb1JIbWJqU2x4UjRnTDFJNVBIMW9KaVJOTkRtd0dOamJ1T1Y4WUlOMUtFRzc5eHlEZ2g0am5LbjFERW9ZMGVNSjlZNlVxT0NKWkJ0NkhyXzVCcTdDc3Z1UGN0U1RORlVYRFktbzB3dmRSbGVGZ3M?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-10T04:24:00+00:00", "published_display": "10 Jul 2026 04:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB): Biotech Stock Pullback Puts Clinical Trial Watchers on Alert", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPaU9jSHAtTXIwcms1ZS1sVXE3QVlEbjlqN0JxUXR6Z3E2MlMwVUZWQU9uOVhuZ2pvY2JuNFNUZV9xckp1WThCY2ZlX2haTmtEaHQ2eFZpbEdUYWczaDZSelpVcTF2dzVmTHl6VFhNc2hheHpBb3hYVmJFSUF1Ykx4QWh6OGRLMjRTSE5taHRnUEZMSjVndkJDN1hRX1B2ckdXVmxab3ZVNkRSZE9LcC1qM0hKMHY?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Debate Builds as Investors Watch the Next Clinical Catalyst", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOY29xd0dnZU05Y1NrS2VjNXlLd05nb1NPZ0tOY0gzb2JoOS1FOHFSNGZlaFg1eEh5ZE5PX0FMaUtoeFlXb2JTNGNOQnlJcXpkN1Jua2lHY0lJRXFyMXpRTEZuYXFPRHJlQjZ5NzB6MWFwVUdGWEZhYk9DU1pyWlJINTZVWWJCTHRNQWZmVnlOaF9lbXdjTDV0aDhNbk9sS1hhY1dqM2J3THExakJXVEN6dF82QQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX: DXB) Lands Major Asia Deal for DMX-200 Kidney Disease Treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZXlNV3FvOVBNUVNHYkJqX1BwemxJaE1UbUljUkVZb1Niak9FdjlXcUFQZk1DdmRvZU1LVHFJSnoxM1JmM2FpQUxkRWRtY1pXdmJsdW8yTjZERUxGZ3p1ZTk2SU43RFN1TS11dlE4SnFRVlU4OU93c3hoY2hrMFdpZnctU3V1aGV3UjlQSkdmZ1draGdDWTFZNmlKMkw1SnNiNDhVMFFsXzZONHJrTkRsLUt0WQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX: DXB) Explodes Higher as Biotech Traders Chase Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNZVE3ZExmT0hoS0tvUWpLV3l4V0xnTXo2YkhkdERWOE1LSDJ6eTIzaFN0ems4a0RiVFV5QzlENDB0YUVna05qaDJaQ1JaQ2V3cVJGN1JxZmxXZnA4bHBQLXFESmNaaGR2ZTBhdUxGSjJXWnVyZnVzbVowbUk3YXctTGh6emZuMjdxbHFiRFN3Q2wyc1pJYzNoTHQ2QndIU19heTBvSlFrTQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix out-licenses DMX-200 to Everest in AU$481M deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOS25XRHhnQ3p4YTBNeGMxMGMzSjZPV3JjVmtzRUtsTlY2TEY4WE9leU92WWhlcVkwcTdKWHJEa0dUMVB2bkl1UENwa29aTzlxMXhMQ3R5d1hDOTUwajJvSUpSTHFxa2phdUdxSXNuQUM3Y3B4RXRnMkZaTFBHOWZKYm9RTzZCdS1ISlJiM1JVVWd3RTJvQktxc2JjYw?oc=5", "source_name": "BioWorld News", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix inks Asian licensing deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwJBVV95cUxNWFVSZFdoNGRHZnUwN3VpNzU3OHpuaXp2YlQzWjlLSXNfWERnSHgxbG9WMlFENDVLNDdvdDVzX2pGaVpxaWx3aUY4VmItNF9BX3JCZjZQeGJvenpzMnh1QjlJWWZObXNCYU9BdUFjZzg3NnFGQ3NscW90MFdIN0FodGhOakpoVTRrbXQ4LWNGUjBmVm44TmpEbnRsbWhiSm52VnZYUGY5QXpRWU90UE03dGxVOE96SHRaaXlQd0QtclNjZVdER3Q0Zmd6QUpPQWNhZDBTODUxVVdiNlVKTGdicjJUb2VxZncxTjdGUTh0T0szSWNzODdfeHZDZXFnWFBvWHJyMTBOeFM2Wm95cURNY0h6RdIBmAJBVV95cUxONkk2ODZpYjVLTG5VcDMwY0x5WUlTTkgtcmY1eUZKa1lFZmZ0R29jQXJodTI3bE9lZ2pKZUdRY05leXhuclI3Rng5cmZtZy04UWJ4dHBPYjdhcDZjUjNrUjVwdzlPNHZZcVN1R0tRazF5WHlUamhtdmc4MS1rRFBFTFRmdks5LW5MdXI1QTg5VkdqOGcyaEtZeXpkR2JhQnlEX0JvWEt6dWJmT3lZeVJsdFpDNVJGdUZTN0lTYU9aLWVtZFpFckc4QU9QTXdHWHBuekZCdmNfWTdpSjVsdGdaY0VuQlQyWWFpbDBmZFkxdkllb3ItOTgzcVgtc2haay1ETkRxTk9CUWNnYXViN0xjRy1rZXN1OEVK?oc=5", "source_name": "The Australian", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brokers see upside in Dimerix as phase III kidney disease drug trial progresses", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQZ3hrYVo4RmdhS1lSQTBheFhRaVp1TE5QYmx2dlhfZkRGY1JEVmw5aEJxTERzdm5uU19sT2JxdFVsNUhUZFRMVU41ZTV5VXNEZXRFZVhqcUNSRUloTS1ObVJ1Qk95RGs3Rm15bndST3dFSnRKNnBKNEtzV1I1a3dWZ3lrVzR6NWRLS25XcE1ZWk9vLU4ybUdjNHJGSktjUHEyYTBYdjEzWndRZUhJZHFBdnJB?oc=5", "source_name": "Stockhead", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Stock Slide Explained: The Key Factors Investors Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPV3lkQW5NOEJWTlBfLV84dmt5aldXQlRDZFoyUUxLLVNaSHFhRGxHSGpBcXR5OXljek1nRGREaWJwOTd4V21uM254dkE3MFMybE0zQTBDOExOZWNCNHRDOUlxTlRTRVdBMkVkWXRiMUptc0FjOWx2Vk9RSktvTlAtbHBYUEhDbklzb0lvRXdoN1owUFdvNFFlcnhONlJES0pCT3E5ODM3R1FpekVmWnZtMEJ3UkNEZw?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Builds Momentum as DMX-200 Advances Through Pivotal Phase 3 Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPbDVuR29WMHhDYXlQSjlmVkUydTkxSFVUS2NnaG1fS2hRNUVRR056TjJINE1hSTJwZ1puN1RhVGxJc3JFNmcyUjZnc3J6TnNkNGNRQ096QXE0Vk9Lenp3RUtPUFFRTGNLQVNsSW0yQ29ZT2d4bWd4WWxod2hfRzFuV3hlVHl4dVhibUxkUFRsa3NNNU1EX2dYTzQwQ3ZPMDlFOGJpVGRwOWZVT0dMRGRHc01Cc091dmI2cHNN?oc=5", "source_name": "Kalkine", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix doses final patient in Phase III trial", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioMarin\u2019s acquisition of Amicus adds momentum to Dimerix\u2019s Phase 3 kidney candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPc1JDcnZMX3dDMmNYdy1mZ0ViTS1kYlRIRXpxdGdobF9mTmNqM1BYSkhnak5lNzlYSnp5MVk5c0JIY1VPMkxoMFVDMlBWRHgteV9udGVNZEdhMnY2QzROV2V3TXl0RVJtUkZlMHY2dVFxMl9kclRyZlZmRFh4VXFwTlVnYk5VY01UVGduVHFYMzFaVnVPeVdHODBWSS00LVpWM2Zjck5QTktDVVF4Y29vTGh0dDBpaDM0Q2c?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Dimerix is sparking a major push into Asia-Pacific\u2019s biotech boom", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNM1Y0VlQta1d6M3FtQTRaZlU4UTRkY01OcmZmZDFLRVlNdE54UVpLTlhwQ0k0ZF9GM2hDS0I5SnZoc1VaSjZzbUQtZU5zV0o2TjRrdWpyUTJwQlhteUVSencwNWxOdnRBWU90ZE0xRktLRnlFSW43YjRSVzRsRm1tb1hxTUdmeFpqajFVc1YzeU0wX001VlVCMXBxUlV2Yi1XdlBtVElhTGdnZw?oc=5", "source_name": "Stockhead", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Dimerix Ltd (ASX:DXB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9sZWQ0QXRCcDktXzdBUGxsUGlvS2c3WUp2Tmgyc3JWSjFQcllUT2VDTFgwRmRhU2RTQnNyMkltYUVTeE8xSkpaZzZ5Rnk0OG9T?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T13:15:05+00:00", "published_display": "30 Oct 2025 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Dimerix acquires phase 2-ready kidney injury treatment DMX-652 By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNTjlmMzdKUzgyS09qLU05MnNkbEpnNVV6V3F2QnVfZUpBa2hyd0YxS29uNWZqT01tWk1UT3VIbzAtdDY1czR1TlVnZDYzRnBXTDBTMFlhT2VhWUtFZkhNdHhfNGxiYk5Leml4MncwTWUtbzJJMU14cndReGJwdks3RVhXOUpoU3J5dFZHXzYyMFR0aG0xTlNMeWZSX1NmY1NCbkNIMGl3NWUxUTNFLW96TG1TNjNpVnNFZUgzSU1ia2JIam5RMWU0YWFXVVl5dw?oc=5", "source_name": "Investing.com Australia", "published_at": "2026-07-17T14:51:40+00:00", "published_display": "17 Jul 2026 14:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxPN09tTG11WmdwZFBKUENCa0FzeGVLN2dNdzJUMVJ3alhDYklGajh6ZDBwOEdYeGVkZnVEWUF0dkdicnBiT2xMMnVYZ1pOQ0YybVVnWW90QS1QOElGSWNaS3Q0Tm16dC1iYzZUVG1ObkNDbEhBbnVKZGVZa0UxU3pHZjdBcUduNmpHOUhJLUZuYWozTkpmYUlWX1FaNmQzeGl3NXVfTERWWDdrZ2pkRzdzVXFadFZfU29Eb1plWF94cFYtdThZWUhLaGlnN3Y1ZVBFLUhmajFRdE16RU5nS1NrRllOVQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-17T06:58:00+00:00", "published_display": "17 Jul 2026 06:58", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix Limited (ASX:DXB) Shares Rise 4.17% Intraday as the DMX-200 Kidney Story Gathers Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQWEpfcTRETlAxbzZUQW8xYnZOaXdLNzBkZ3VHbWdSUE5ZZ19FZE5vdlBQOEZjRmdCbnpDRTR4TUhhd2NhZ25mWGhKY0xSNlprOUpfczJ3MnhHZlN0cTlDUmFjSmRVTkFReTBnOEtic2w1MGdoSjBWYmtXNEozSmFpWEQ0NXh3Ql9zZWhoUWx5Q21weDJpSTlBbDRHQjhXUEpvdGt0YVlkeldGbDhmN3hEa3Rsc1BsNUdadk9nQzFNTDU5MW9BOTl3eHNZQkROQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T04:21:00+00:00", "published_display": "17 Jul 2026 04:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Is Fueling Today's Rally in Dimerix (ASX:DXB) Share Price?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNMl9pZHRQSi1nWFBDZkNGRnFWOEMtZEtPTDJOUmtka3FMbk42VTJtcWVxQlZKa2JBcFJzNnB2TVJQTjYxc1M2ejR4U245ci1MNlVZdzJtNENzWTVPZWFzcmM5dGhNX3FuZ18wcnZHZFhRdjIwdUN1Q2xtOGZFV0dTV0NFMlFQNUtwM3pOX2l0VkpNUTlrY3Y0QVppM3BpUQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-17T02:44:00+00:00", "published_display": "17 Jul 2026 02:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix Acquires Therapeutic Asset From UK-Based Firm; Shares Up 8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWV9LUXJmMWhoTFdyeUtxTS1VaDJfREl6TThmMmdVSUo2a3lQb0piVzR1RF8yQ3N2V1p3cmVQYzNlYmdubkpXckd1NGNqVWd6LVYxVzFua0plenQtN254UTB4VVhqUWU3aHFxVlRkcXI3bVMzZ0Q3V3BBRFRvOEY1NngtVE9PZVoyQUFVd2lQd3BfSW9IZWFNYTJZc2RHcTBzbGd0MG5rUW82R0oxeHZZS29FRktHSTFvNXB3emtybWhIUF9Db2E5VzRhZWxnMTV3RkRPcm1YYw?oc=5", "source_name": "Moomoo", "published_at": "2026-07-17T02:16:08+00:00", "published_display": "17 Jul 2026 02:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) buys DMX-652 and quietly rebuilds its story", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTFB1SUxsUXg5VS1Gd29UbEZmVXRyV3JySVJhNWJFOWNjNDFBTUU0X2FjTUp3NzM3MHF2bGg2QjZRaDJRa1pUb2RlSDBtMk5hLWE2dHpMdlJIRTM2V2tVWGVJWk1XbE04ak9jZU5qRi1DZw?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-07-17T01:15:46+00:00", "published_display": "17 Jul 2026 01:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Shares Slip: Is the Market Underestimating the Biotechnology Company's Clinical Pipeline?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQOEJsck1DeWMxRTBpcGlWTzU0eVVqTXg4N0JwVmlFUVJuRmZDNlNsa0pkWTlaRjluQ0NBclhXWGZKQlZndW5PQzVwN1F5SVFOdHVJUmZxZHRBRk16dkRtbTZRbzkxRUp1dWFEVHpON296NEVZdnNfZmlhZ3d0QVF3aTRsT0Jpa2F1MDRTdmhoOThReEtpREVNY3ZwNjJpZng1WHJGWEU5RlM4dUJKQTY0U24zbHJVeXVuT2JzR091ZmR2ZjZreEUwZ05uWXppZDRucTdKU1pJUQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:13:00+00:00", "published_display": "13 Jul 2026 07:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could Dimerix (ASX:DXB) Be Approaching a Defining Regulatory Phase?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbE5lN0xFMTJ6bkwxSWlBQmU0V2swQjRfWGFPYzdITXRicUxxalZ1YW96TGtZNGtPWndQeThxb1JIbWJqU2x4UjRnTDFJNVBIMW9KaVJOTkRtd0dOamJ1T1Y4WUlOMUtFRzc5eHlEZ2g0am5LbjFERW9ZMGVNSjlZNlVxT0NKWkJ0NkhyXzVCcTdDc3Z1UGN0U1RORlVYRFktbzB3dmRSbGVGZ3M?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-10T04:24:00+00:00", "published_display": "10 Jul 2026 04:24", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB): Biotech Stock Pullback Puts Clinical Trial Watchers on Alert", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPaU9jSHAtTXIwcms1ZS1sVXE3QVlEbjlqN0JxUXR6Z3E2MlMwVUZWQU9uOVhuZ2pvY2JuNFNUZV9xckp1WThCY2ZlX2haTmtEaHQ2eFZpbEdUYWczaDZSelpVcTF2dzVmTHl6VFhNc2hheHpBb3hYVmJFSUF1Ykx4QWh6OGRLMjRTSE5taHRnUEZMSjVndkJDN1hRX1B2ckdXVmxab3ZVNkRSZE9LcC1qM0hKMHY?oc=5", "source_name": "Kalkine", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Debate Builds as Investors Watch the Next Clinical Catalyst", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOY29xd0dnZU05Y1NrS2VjNXlLd05nb1NPZ0tOY0gzb2JoOS1FOHFSNGZlaFg1eEh5ZE5PX0FMaUtoeFlXb2JTNGNOQnlJcXpkN1Jua2lHY0lJRXFyMXpRTEZuYXFPRHJlQjZ5NzB6MWFwVUdGWEZhYk9DU1pyWlJINTZVWWJCTHRNQWZmVnlOaF9lbXdjTDV0aDhNbk9sS1hhY1dqM2J3THExakJXVEN6dF82QQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX: DXB) Lands Major Asia Deal for DMX-200 Kidney Disease Treatment", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZXlNV3FvOVBNUVNHYkJqX1BwemxJaE1UbUljUkVZb1Niak9FdjlXcUFQZk1DdmRvZU1LVHFJSnoxM1JmM2FpQUxkRWRtY1pXdmJsdW8yTjZERUxGZ3p1ZTk2SU43RFN1TS11dlE4SnFRVlU4OU93c3hoY2hrMFdpZnctU3V1aGV3UjlQSkdmZ1draGdDWTFZNmlKMkw1SnNiNDhVMFFsXzZONHJrTkRsLUt0WQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX: DXB) Explodes Higher as Biotech Traders Chase Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNZVE3ZExmT0hoS0tvUWpLV3l4V0xnTXo2YkhkdERWOE1LSDJ6eTIzaFN0ems4a0RiVFV5QzlENDB0YUVna05qaDJaQ1JaQ2V3cVJGN1JxZmxXZnA4bHBQLXFESmNaaGR2ZTBhdUxGSjJXWnVyZnVzbVowbUk3YXctTGh6emZuMjdxbHFiRFN3Q2wyc1pJYzNoTHQ2QndIU19heTBvSlFrTQ?oc=5", "source_name": "Kalkine", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix out-licenses DMX-200 to Everest in AU$481M deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOS25XRHhnQ3p4YTBNeGMxMGMzSjZPV3JjVmtzRUtsTlY2TEY4WE9leU92WWhlcVkwcTdKWHJEa0dUMVB2bkl1UENwa29aTzlxMXhMQ3R5d1hDOTUwajJvSUpSTHFxa2phdUdxSXNuQUM3Y3B4RXRnMkZaTFBHOWZKYm9RTzZCdS1ISlJiM1JVVWd3RTJvQktxc2JjYw?oc=5", "source_name": "BioWorld News", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix inks Asian licensing deal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brokers see upside in Dimerix as phase III kidney disease drug trial progresses", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQZ3hrYVo4RmdhS1lSQTBheFhRaVp1TE5QYmx2dlhfZkRGY1JEVmw5aEJxTERzdm5uU19sT2JxdFVsNUhUZFRMVU41ZTV5VXNEZXRFZVhqcUNSRUloTS1ObVJ1Qk95RGs3Rm15bndST3dFSnRKNnBKNEtzV1I1a3dWZ3lrVzR6NWRLS25XcE1ZWk9vLU4ybUdjNHJGSktjUHEyYTBYdjEzWndRZUhJZHFBdnJB?oc=5", "source_name": "Stockhead", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Stock Slide Explained: The Key Factors Investors Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPV3lkQW5NOEJWTlBfLV84dmt5aldXQlRDZFoyUUxLLVNaSHFhRGxHSGpBcXR5OXljek1nRGREaWJwOTd4V21uM254dkE3MFMybE0zQTBDOExOZWNCNHRDOUlxTlRTRVdBMkVkWXRiMUptc0FjOWx2Vk9RSktvTlAtbHBYUEhDbklzb0lvRXdoN1owUFdvNFFlcnhONlJES0pCT3E5ODM3R1FpekVmWnZtMEJ3UkNEZw?oc=5", "source_name": "Kalkine", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix (ASX:DXB) Builds Momentum as DMX-200 Advances Through Pivotal Phase 3 Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPbDVuR29WMHhDYXlQSjlmVkUydTkxSFVUS2NnaG1fS2hRNUVRR056TjJINE1hSTJwZ1puN1RhVGxJc3JFNmcyUjZnc3J6TnNkNGNRQ096QXE0Vk9Lenp3RUtPUFFRTGNLQVNsSW0yQ29ZT2d4bWd4WWxod2hfRzFuV3hlVHl4dVhibUxkUFRsa3NNNU1EX2dYTzQwQ3ZPMDlFOGJpVGRwOWZVT0dMRGRHc01Cc091dmI2cHNN?oc=5", "source_name": "Kalkine", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Dimerix doses final patient in Phase III trial", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Australian", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioMarin\u2019s acquisition of Amicus adds momentum to Dimerix\u2019s Phase 3 kidney candidate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPc1JDcnZMX3dDMmNYdy1mZ0ViTS1kYlRIRXpxdGdobF9mTmNqM1BYSkhnak5lNzlYSnp5MVk5c0JIY1VPMkxoMFVDMlBWRHgteV9udGVNZEdhMnY2QzROV2V3TXl0RVJtUkZlMHY2dVFxMl9kclRyZlZmRFh4VXFwTlVnYk5VY01UVGduVHFYMzFaVnVPeVdHODBWSS00LVpWM2Zjck5QTktDVVF4Y29vTGh0dDBpaDM0Q2c?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-12-22T08:00:00+00:00", "published_display": "22 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Dimerix is sparking a major push into Asia-Pacific\u2019s biotech boom", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNM1Y0VlQta1d6M3FtQTRaZlU4UTRkY01OcmZmZDFLRVlNdE54UVpLTlhwQ0k0ZF9GM2hDS0I5SnZoc1VaSjZzbUQtZU5zV0o2TjRrdWpyUTJwQlhteUVSencwNWxOdnRBWU90ZE0xRktLRnlFSW43YjRSVzRsRm1tb1hxTUdmeFpqajFVc1YzeU0wX001VlVCMXBxUlV2Yi1XdlBtVElhTGdnZw?oc=5", "source_name": "Stockhead", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Dimerix Ltd (ASX:DXB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9sZWQ0QXRCcDktXzdBUGxsUGlvS2c3WUp2Tmgyc3JWSjFQcllUT2VDTFgwRmRhU2RTQnNyMkltYUVTeE8xSkpaZzZ5Rnk0OG9T?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T13:15:05+00:00", "published_display": "30 Oct 2025 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 88, "total_relevant": 21, "sentiment_summary": {"positive": 3, "negative": 0, "neutral": 18, "score": 52, "total": 21, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 8.25, "count": 15}, {"event": "deals", "label": "Deals and strategy", "weight": 2.75, "count": 5}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.24, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 45.5, "twelve_week_move": -39.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.067378, "market_dynamics_buy_signal": false, "relative_strength": -43.33551, "fair_value_gap": -35.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.3702, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +45.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 9}, {"label": "The Australian", "count": 2}, {"label": "Stockhead", "count": 2}, {"label": "Investing.com Australia", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "Stocks Down Under", "count": 1}, {"label": "Kalkine Media", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Deals and strategy", "count": 5}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, +45.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Dimerix acquires phase 2-ready kidney injury treatment DMX-652 By Investing.com"}], "updated_at": "2026-07-18T08:06:24.287438+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}